ARGX argenx N.V.: Accounting Value per Share

Graphic logo of argenx SE (ARGX)

The book value per common share for argenx SE (ARGX) reflects capital dynamics, with the current metric standing at 135.09. The implementation of sustainable manufacturing and energy-efficient laboratories supports business resilience. Growth is driven by the success of myasthenia gravis therapy and the expansion of sales markets. The rapid rollout of Vyvgart for new pathologies creates real momentum, despite significant expenditures on current clinical developments.

argenx N.V. (ARGX): Share Book Value from 07/04/2022 to 10/27/2026

argenx.com - analytical breakdowns and key metrics (ARGX)

- price and consensus price forecast:
Stock Price Argenx|ARGX - Analyst Target Range
- market capitalization data:
Market Valuation argenx SE|ARGX - Business Value
- book capitalization data:
Net Assets per Single Share argenx|ARGX - Net Asset Value|Market Capitalization to Book Value Ratio argenx.com|ARGX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital argenx SE|ARGX - Long-Term Debt to Capital|Short-Term Debt to Equity argenx|ARGX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio argenx SE
Fundamental company valuation:Argenx - ARGX
Manufactured products of argenx

Developing universal antibodies for the treatment of autoimmune pathologies requires significant R&D capital expenditures. The book value per share reflects the portion of net assets available to the owner of each security upon business liquidation. Analyzing the current BVPS value on GURU.Markets allows for an assessment of the real value of capital relative to the market price. The steady growth of this indicator confirms the financial stability of argenx SE (ARGX). This metric serves as the foundation for determining the company's fair capitalization.

Competitors of argenx SE (ARGX)

Book Value per Share BNTX|Abivax Pharma (ABVX) - Book Value of One Share|Accounting Value per Share ADMA Biologics|PTGX (protagonist-inc.com) - Equity per Share|Net Assets per Single Share Immunovant IMVT|Share Book Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Book Value per Share|Accounting Value of a Share Adaptive Biotechnologies Inc. (ADPT)|Book Value per Share CLDX (Celldex Therapeutics)|auriniapharma.com - Book Value per Share|Net Assets per Single Share BioCryst Pharmaceuticals (BCRX)|VERA: Accounting Value of a Share|DNTH (Dianthus Pharma) - Net Assets per Single Share|Pharvaris Pharma (PHVS) - Accounting Value per Share|ABCL (AbCellera Biologics Inc) - Book Value per Share|Book Value per Share tourmalinebio.com (TRML)|Precigen (PGEN) - Accounting Value per Share|Accounting Value of a Share Pharming Group NV (PHAR)|Book Value per Share NKTR|Upstream Pharma - Net Assets per Share|ZBIO: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Net Asset Value per Share Astria Therapeutics Inc ATXS|enGene Bio - Book Value per Share|RAPT: Book Value per Share|Net Assets per Single Share aerovatetx.com JBIO|aclaristx.com (ACRS) - Accounting Value of a Share|Kyverna Therapeutics, Inc. - Book Value per Share|Book Value of One Share Tiziana Life Sciences Ltd.|Cabaletta Bio, Inc - Book Value per Share|Net Asset Value per Share VTYX (Ventyx Biosciences, Inc)|THTX - Net Assets per Single Share|AVTX - Equity per Share|Eledon Pharmaceuticals, Inc. (ELDN) - Accounting Value per Share|Agenus, Inc. (AGEN) - Equity per Share|Accounting Value per Share Climb Bio, Inc. CLYM|ZURA (Zura Bio Ltd) - Accounting Value of a Share|ATYR: Net Assets per Single Share|Net Assets per Share Adagene Corp|ImageneBio Inc - Book Value per Share|Net Asset Value per Share shattucklabs.com (STTK)|Book Value per Share EQ (Equillium)|Connect Biopharma Holdings - Book Value per Share|Net Assets per Single Share Immunic Inc (IMUX)|ATRA - Accounting Value of a Share|Book Value per Share IFRX (inflarx.de)|Book Value of One Share X4 Pharmaceuticals Inc.|Accounting Value per Share Adicet Bio Inc. (ACET)|Equity per Share CELU|INMB - Net Assets per Single Share|Share Book Value barinthusbio.com (BRNS)|Book Value per Share Kezar Life Sciences, Inc.|Accounting Value of a Share SAB Biotherapeutics Inc. SABS|Akari Therapeutics plc - Book Value per Share|ENLV: Book Value per Share|Net Assets per Single Share q32bio.com QTTB|GOVX (geovax.com) - Accounting Value of a Share|Net Assets per Single Share EDSA|Accounting Value per Share iBio Inc|Book Value per Share CARM|Book Value per Share XTL Bio XTLB|Accounting Value per Share Bolt Biotherapeutics, Inc.|Accounting Value of a Share HCW Biologics, Inc. HCWB|Book Value per Share APVO (Aptevo)|AIM: Net Assets per Share|ADTX (aditxt.com) - Net Assets per Single Share|GRI (GRI Bio Corporation) - Accounting Value per Share|Net Assets per Single Share XRTX|Accounting Value per Share reshapelifesciences.com (HIND)|Accounting Value per Share REVB|Book Value per Share INDP (Indaptus Therapeutics Inc)|SCNI - Net Assets per Single Share|Equity per Share CalciMedica Inc CALI|AFMD (Affimed Therapeutics) - Book Value per Share|ALLK - Net Asset Value per Share|HOOK: Book Value per Share|IGMS (IGM Biosciences) - Book Value per Share|ITOS - Net Assets per Single Share|Accounting Value of a Share Ocean Biomedical Corp|TCBP: Book Value per Share|Book Value of One Share thirdharmonicbio.com (THRD)